stoxline Quote Chart Rank Option Currency Glossary
Akili, Inc. (AKLI)
0.4833  0.013 (2.83%)    11-29 09:48
Open: 0.463
High: 0.4833
Volume: 3,223
Pre. Close: 0.47
Low: 0.463
Market Cap: 38(M)
Technical analysis
2023-11-29 9:13:59 AM
Short term     
Mid term     
Targets 6-month :  0.59 1-year :  0.69
Resists First :  0.5 Second :  0.59
Pivot price 0.46
Supports First :  0.39 Second :  0.33
MAs MA(5) :  0.48 MA(20) :  0.44
MA(100) :  0.76 MA(250) :  1.15
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  78.3 D(3) :  86.4
RSI RSI(14): 48.7
52-week High :  2.2 Low :  0.33
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AKLI ] has closed below upper band by 43.0%. Bollinger Bands are 54.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.5 - 0.5 0.5 - 0.51
Low: 0.46 - 0.47 0.47 - 0.47
Close: 0.47 - 0.47 0.47 - 0.47
Company Description

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Headline News

Thu, 09 Nov 2023
Akili Reports Third Quarter 2023 Financial Results and Provides Business Update - Yahoo Finance

Mon, 06 Nov 2023
Hims & Hers Health, Inc. (HIMS) Reports Q3 Loss, Tops Revenue ... - Nasdaq

Thu, 19 Oct 2023
Akili to Host Third Quarter Financial Results Conference Call and ... - Business Wire

Thu, 12 Oct 2023
Employees with ADHD Aren't Reaching Their Full Potential at Work ... - Business Wire

Fri, 06 Oct 2023
Akili Announces Leadership Transition - Business Wire

Thu, 21 Sep 2023
Akili Releases EndeavorOTC™ on Android™ Devices, Expanding ... - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Health Information Services
Shares Out 0 (M)
Shares Float 78 (M)
Held by Insiders 2.52e+007 (%)
Held by Institutions 18.4 (%)
Shares Short 92 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -7.466e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -2 %
Return on Assets (ttm) 624.7 %
Return on Equity (ttm) -36.3 %
Qtrly Rev. Growth 1.04e+006 %
Gross Profit (p.s.) 507.44
Sales Per Share -45.33
EBITDA (p.s.) -79194.6
Qtrly Earnings Growth -1.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -70 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 0.79
Stock Dividends
Dividend 0
Forward Dividend 74250
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android